Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001209191-21-043332

Options or other derivatives

  • Director acquired 11,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Krainer Adrian R. · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-08 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +11,650 $40.37 2031-06-07 11,650 11,650 D
Loading xslF345X03/doc4.xml…